About
Stem Cell Therapy, Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalStem Cell & Cellular Therapy
Clinical Trials (24)
View allTotal Trials
24
As Lead Sponsor
16
As Collaborator
8
Total Enrollment
2,024
By Phase
PHASE2: 14NA: 1PHASE4: 1PHASE3: 6PHASE1: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 16TERMINATED: 7WITHDRAWN: 1
Clinical Trials Pipeline24 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT03866954Collaborator
Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy
PHASE2Withdrawn
Started: Nov 30, 2024 · Completed: Dec 31, 2027
NCT04971005Collaborator
Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled Trial
PHASE2Terminated
1 participants
Started: Aug 27, 2021 · Completed: Feb 4, 2022
NCT02757989Collaborator
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk
NACompleted
79 participants
Started: May 31, 2016 · Completed: Jun 7, 2024
NCT02377193Collaborator
Simulect Versus ATG in Sensitized Renal Transplant Patient
PHASE4Completed
60 participants
Started: Sep 30, 2013 · Completed: Jan 31, 2017
NCT01582048Collaborator
Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
PHASE2Terminated
9 participants
Started: Apr 30, 2012 · Completed: Aug 17, 2016
Locations (1)
Headquarters
Grafelfing, Germany
Map
Loading map...